Literature DB >> 22309134

Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.

Angela C Brown1, Kathleen Boesze-Battaglia, Yurong Du, Frank P Stefano, Irene R Kieba, Raquel F Epand, Lazaros Kakalis, Philip L Yeagle, Richard M Epand, Edward T Lally.   

Abstract

The Gram-negative bacterium, Aggregatibacter actinomycetemcomitans, is a common inhabitant of the human upper aerodigestive tract. The organism produces an RTX (Repeats in ToXin) toxin (LtxA) that kills human white blood cells. LtxA is believed to be a membrane-damaging toxin, but details of the cell surface interaction for this and several other RTX toxins have yet to be elucidated. Initial morphological studies suggested that LtxA was bending the target cell membrane. Because the ability of a membrane to bend is a function of its lipid composition, we assessed the proficiency of LtxA to release of a fluorescent dye from a panel of liposomes composed of various lipids. Liposomes composed of lipids that form nonlamellar phases were susceptible to LtxA-induced damage while liposomes composed of lipids that do not form non-bilayer structures were not. Differential scanning calorimetry demonstrated that the toxin decreased the temperature at which the lipid transitions from a bilayer to a nonlamellar phase, while (31) P nuclear magnetic resonance studies showed that the LtxA-induced transition from a bilayer to an inverted hexagonal phase occurs through the formation of an isotropic intermediate phase. These results indicate that LtxA cytotoxicity occurs through a process of membrane destabilization.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309134      PMCID: PMC3412409          DOI: 10.1111/j.1462-5822.2012.01762.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  60 in total

1.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

2.  Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  M Iwase; E T Lally; P Berthold; H M Korchak; N S Taichman
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes.

Authors:  G Menestrina; N Mackman; I B Holland; S Bhakdi
Journal:  Biochim Biophys Acta       Date:  1987-11-27

4.  Phosphorus nuclear magnetic resonance studies of lipid-protein interactions: human erythrocyte glycophorin and phospholipids.

Authors:  P L Yeagle; D Kelsey
Journal:  Biochemistry       Date:  1989-03-07       Impact factor: 3.162

5.  Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates.

Authors:  R Benz; A Schmid; W Wagner; W Goebel
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

6.  The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes.

Authors:  A Ludwig; T Jarchau; R Benz; W Goebel
Journal:  Mol Gen Genet       Date:  1988-11

7.  Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins.

Authors:  E T Lally; E E Golub; I R Kieba; N S Taichman; J Rosenbloom; J C Rosenbloom; C W Gibson; D R Demuth
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

8.  Identification of a hemolysin from Actinobacillus pleuropneumoniae and characterization of its channel properties in planar phospholipid bilayers.

Authors:  G Lalonde; T V McDonald; P Gardner; P D O'Hanley
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

9.  Cholesterol sulfate inhibits the fusion of Sendai virus to biological and model membranes.

Authors:  J J Cheetham; R M Epand; M Andrews; T D Flanagan
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

10.  Membrane fusion and inverted phases.

Authors:  H Ellens; D P Siegel; D Alford; P L Yeagle; L Boni; L J Lis; P J Quinn; J Bentz
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

View more
  20 in total

1.  Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.

Authors:  Marianne Skals; Randi G Bjaelde; Jesper Reinholdt; Knud Poulsen; Brian S Vad; Daniel E Otzen; Jens Leipziger; Helle A Praetorius
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

2.  Pore forming activity of the potent RTX-toxin produced by pediatric pathogen Kingella kingae: Characterization and comparison to other RTX-family members.

Authors:  Iván Bárcena-Uribarri; Roland Benz; Mathias Winterhalter; Eleonora Zakharian; Nataliya Balashova
Journal:  Biochim Biophys Acta       Date:  2015-04-07

3.  Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.

Authors:  A C Brown; E Koufos; N V Balashova; K Boesze-Battaglia; E T Lally
Journal:  Mol Oral Microbiol       Date:  2015-10-12       Impact factor: 3.563

4.  Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.

Authors:  Angela C Brown; Nataliya V Balashova; Richard M Epand; Raquel F Epand; Alvina Bragin; Scott C Kachlany; Michael J Walters; Yurong Du; Kathleen Boesze-Battaglia; Edward T Lally
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

5.  Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.

Authors:  Patrik Nygren; Nataliya Balashova; Angela C Brown; Irene Kieba; Anuradha Dhingra; Kathleen Boesze-Battaglia; Edward T Lally
Journal:  Cell Microbiol       Date:  2018-11-28       Impact factor: 3.715

Review 6.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

7.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

8.  Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.

Authors:  M J Walters; A C Brown; T C Edrington; S Baranwal; Y Du; E T Lally; K Boesze-Battaglia
Journal:  Mol Oral Microbiol       Date:  2013-05-16       Impact factor: 3.563

9.  Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.

Authors:  Joshua N Webb; Evan Koufos; Angela C Brown
Journal:  J Membr Biol       Date:  2016-04-02       Impact factor: 1.843

10.  Catechin-mediated restructuring of a bacterial toxin inhibits activity.

Authors:  En Hyung Chang; Joanne Huang; Zixiang Lin; Angela C Brown
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-10-17       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.